comparemela.com

Latest Breaking News On - Sigyn therapy - Page 8 : comparemela.com

Sigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets

Sigyn Therapeutics Announces Successful Completion of Animal Pilot Study

Sigyn Therapeutics Announces Successful Completion of Animal Pilot Study
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Nic-johnson
David-schull
Aethlon-hemopurifier
Craig-roberts
Jim-joyce
European-union
Time-magazine
Sigyn-therapeutics-inc
Drug-administration
Health-canada

Sigyn Therapeutics Announces Rapid Elimination of Hepatic Toxins from Human Blood Plasma

Sigyn Therapeutics Announces Rapid Elimination of Hepatic Toxins from Human Blood Plasma
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United-states
California
San-diego
Nic-johnson
David-schull
Jim-joyce
Sigyn-therapeutics-inc
Drug-administration
Russo-partners
Sigyn-therapy
Hepatic-encephalopathy
Investigational-device-exemption

Sigyn Therapeutics Reports Preliminary Results of Hepatic Encephalopathy Toxin Study

Sigyn Therapeutics Reports Preliminary Results of Hepatic Encephalopathy Toxin Study
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United-states
California
San-diego
Nic-johnson
David-schull
Jim-joyce
Sigyn-therapeutics-inc
Drug-administration
Russo-partners
Sigyn-therapy
Hepatic-encephalopathy
Investigational-device-exemption

The Closing Bell Featuring Sigyn Therapeutics

Press release content from Globe Newswire. The AP news staff was not involved in its creation. The Closing Bell Featuring Sigyn Therapeutics Sigyn Therapeutics, Inc.April 21, 2021 GMT The Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) via NewMediaWire Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announces that its Chairman and CEO, Jim Joyce, will be featured on the Closing Bell videoconference hosted by Force Family Offices at 4pm Eastern today.  This interactive event provides investors with an opportunity to talk directly with Mr. Joyce regarding the advancement of Sigyn Therapy™, a novel blood purification technology designed to treat sepsis and other life-threatening conditions that are induced by cytokine storm syndrome.  Also participating in the event will

California
United-states
San-diego
Rob-goldman
Jim-joyce
White-fund
Sigyn-therapeutics-inc
Goldman-small-cap-research
Family-office
Newmediawire-sigyn-therapeutics-inc
Contact-sigyn-therapeutics-inc
Rob-goldman-at-small-cap-research

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.